| Market Capitalization (Millions $) |
1,693 |
| Shares
Outstanding (Millions) |
532 |
| Employees |
600 |
| Revenues (TTM) (Millions $) |
55 |
| Net Income (TTM) (Millions $) |
-519 |
| Cash Flow (TTM) (Millions $) |
131 |
| Capital Exp. (TTM) (Millions $) |
4 |
Business Description
Recursion Pharmaceuticals Inc. is a biotechnology company that uses advanced artificial intelligence (AI), automation, and drug discovery platforms to develop new treatments for various diseases. The company focuses on identifying and targeting rare genetic diseases, as well as finding potential therapeutics for other complex diseases.
Recursion Pharmaceuticals utilizes high-throughput robotic imaging and combines it with deep learning algorithms to rapidly screen thousands of disease models in order to identify novel drug candidates. Their unique approach enables them to generate vast amounts of biological data that can be analyzed to uncover new insights and potential treatments.
The company has a diverse pipeline of drug candidates at various stages of development, covering a range of diseases like neurodegenerative disorders, cancer, and genetic diseases. They collaborate with pharmaceutical companies, academic institutions, and biotech partners to accelerate the discovery and development of new therapeutic options.
Recursion Pharmaceuticals aims to revolutionize drug discovery by integrating modern technology with biology to unlock new breakthroughs in treating diseases that were previously considered challenging. Their innovative approach holds the potential to provide hope for patients suffering from complex diseases and improve the overall efficiency of drug development.
Company Address: 41 S Rio Grande Street Salt Lake City, 84101 UT
Company Phone Number: 269 - 0203 Stock Exchange / Ticker: NASDAQ RXRX
|
177.38 %